skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: In Vitro Polyvinylformaldehyde Particle Compatibility with Chemotherapeutic Drugs Used for Chemoembolization Therapy

Abstract

Purpose: Because the effects of pirarubicin and carboplatin on the physical structure of particles made from polyvinylformaldehyde are not well known, we describe an experiment to test the in vitro polyvinylformaldehyde particle compatibility with these drugs used for chemoembolization of bone metastases. Materials and Methods: Polyvinylformaldehydeparticles (Ultra-Drivalon) were mixed in vitro with either pirarubicinor carboplatin as experimental samples, and with distilled water as control samples, and left for 24 h at 37{sup o}C. The particles used measured 150-250 {mu}m and 600-1000 {mu}m in diameter. Particle morphology, including appearance, overall shape, and surface characteristics were examined using a microscope equipped with a videocamera. Particle size was measured by granulometry. Qualitative and quantitative variables were analyzed using, respectively, the two-sided Fisher's exact test and the Wilcoxon signed-rank rank test for paired values, with a significance level of 0.05. Results: No broken particles or microscopic degradations in the appearance, overall shape, or surface characteristics of any particles were observed. The particle size distribution was not significantly different between the experimental samples containing pirarubicin or carboplatin and the control sample of particles with diameters in the same range. Conclusion: Particles made from polyvinylformaldehyde can be mixed with pirarubicin or carboplatin without any risk ofmore » damaging their physical properties.« less

Authors:
; ; ;  [1];  [2];  [1]
  1. Medical University of Paris 6, 47-83 Boulevard del'Hopital, 75651 Paris Cedex 13, Department of Diagnostic andInterventional Neuroradiology, Pitie-SalpetriereHospital (France)
  2. Cathnet-Science, 6 rue J.A. de Baif-CE 19, 75644 ParisCedex 13, Research and Development Department (France)
Publication Date:
OSTI Identifier:
21088382
Resource Type:
Journal Article
Journal Name:
Cardiovascular and Interventional Radiology
Additional Journal Information:
Journal Volume: 26; Journal Issue: 3; Other Information: DOI: 10.1007/s00270-003-0027-8; Copyright (c) 2003 Springer-Verlag New York, Inc.; www.springer-ny.com; Country of input: International Atomic Energy Agency (IAEA); Journal ID: ISSN 0174-1551
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; DRUGS; IN VITRO; PARTICLE SIZE; PHYSICAL PROPERTIES; THERAPY; VASCULAR DISEASES

Citation Formats

Vallee, Jean-Noel, Guillevin, Remy, Lo, Daouda, Adem, Carmen, Benois, Florence, and Chiras, Jacques. In Vitro Polyvinylformaldehyde Particle Compatibility with Chemotherapeutic Drugs Used for Chemoembolization Therapy. United States: N. p., 2003. Web. doi:10.1007/S00270-003-0027-8.
Vallee, Jean-Noel, Guillevin, Remy, Lo, Daouda, Adem, Carmen, Benois, Florence, & Chiras, Jacques. In Vitro Polyvinylformaldehyde Particle Compatibility with Chemotherapeutic Drugs Used for Chemoembolization Therapy. United States. https://doi.org/10.1007/S00270-003-0027-8
Vallee, Jean-Noel, Guillevin, Remy, Lo, Daouda, Adem, Carmen, Benois, Florence, and Chiras, Jacques. 2003. "In Vitro Polyvinylformaldehyde Particle Compatibility with Chemotherapeutic Drugs Used for Chemoembolization Therapy". United States. https://doi.org/10.1007/S00270-003-0027-8.
@article{osti_21088382,
title = {In Vitro Polyvinylformaldehyde Particle Compatibility with Chemotherapeutic Drugs Used for Chemoembolization Therapy},
author = {Vallee, Jean-Noel and Guillevin, Remy and Lo, Daouda and Adem, Carmen and Benois, Florence and Chiras, Jacques},
abstractNote = {Purpose: Because the effects of pirarubicin and carboplatin on the physical structure of particles made from polyvinylformaldehyde are not well known, we describe an experiment to test the in vitro polyvinylformaldehyde particle compatibility with these drugs used for chemoembolization of bone metastases. Materials and Methods: Polyvinylformaldehydeparticles (Ultra-Drivalon) were mixed in vitro with either pirarubicinor carboplatin as experimental samples, and with distilled water as control samples, and left for 24 h at 37{sup o}C. The particles used measured 150-250 {mu}m and 600-1000 {mu}m in diameter. Particle morphology, including appearance, overall shape, and surface characteristics were examined using a microscope equipped with a videocamera. Particle size was measured by granulometry. Qualitative and quantitative variables were analyzed using, respectively, the two-sided Fisher's exact test and the Wilcoxon signed-rank rank test for paired values, with a significance level of 0.05. Results: No broken particles or microscopic degradations in the appearance, overall shape, or surface characteristics of any particles were observed. The particle size distribution was not significantly different between the experimental samples containing pirarubicin or carboplatin and the control sample of particles with diameters in the same range. Conclusion: Particles made from polyvinylformaldehyde can be mixed with pirarubicin or carboplatin without any risk of damaging their physical properties.},
doi = {10.1007/S00270-003-0027-8},
url = {https://www.osti.gov/biblio/21088382}, journal = {Cardiovascular and Interventional Radiology},
issn = {0174-1551},
number = 3,
volume = 26,
place = {United States},
year = {Sun Jun 15 00:00:00 EDT 2003},
month = {Sun Jun 15 00:00:00 EDT 2003}
}